Japan · Delayed Price · Currency is JPY Techno Medica Statistics
Total Valuation
Techno Medica has a market cap or net worth of JPY 14.60 billion. The enterprise value is 5.92 billion.
| Market Cap | 14.60B |
| Enterprise Value | 5.92B |
Important Dates
The last earnings date was Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Techno Medica has 6.97 million shares outstanding. The number of shares has decreased by -1.40% in one year.
| Current Share Class | 6.97M |
| Shares Outstanding | 6.97M |
| Shares Change (YoY) | -1.40% |
| Shares Change (QoQ) | -1.80% |
| Owned by Insiders (%) | 31.01% |
| Owned by Institutions (%) | 12.03% |
| Float | 3.44M |
Valuation Ratios
The trailing PE ratio is 11.81.
| PE Ratio | 11.81 |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | 13.71 |
| P/OCF Ratio | 13.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.96, with an EV/FCF ratio of 5.56.
| EV / Earnings | 4.88 |
| EV / Sales | 0.51 |
| EV / EBITDA | 2.96 |
| EV / EBIT | 3.10 |
| EV / FCF | 5.56 |
Financial Position
The company has a current ratio of 6.23
| Current Ratio | 6.23 |
| Quick Ratio | 5.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.77% and return on invested capital (ROIC) is 25.35%.
| Return on Equity (ROE) | 8.77% |
| Return on Assets (ROA) | 7.25% |
| Return on Invested Capital (ROIC) | 25.35% |
| Return on Capital Employed (ROCE) | 13.63% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | 48.87M |
| Profits Per Employee | 5.07M |
| Employee Count | 239 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, Techno Medica has paid 531.00 million in taxes.
| Income Tax | 531.00M |
| Effective Tax Rate | 30.46% |
Stock Price Statistics
The stock price has increased by +5.30% in the last 52 weeks. The beta is 0.24, so Techno Medica's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +5.30% |
| 50-Day Moving Average | 2,039.78 |
| 200-Day Moving Average | 2,175.05 |
| Relative Strength Index (RSI) | 50.76 |
| Average Volume (20 Days) | 10,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Techno Medica had revenue of JPY 11.68 billion and earned 1.21 billion in profits. Earnings per share was 177.42.
| Revenue | 11.68B |
| Gross Profit | 5.48B |
| Operating Income | 1.91B |
| Pretax Income | 1.74B |
| Net Income | 1.21B |
| EBITDA | 2.00B |
| EBIT | 1.91B |
| Earnings Per Share (EPS) | 177.42 |
Balance Sheet
The company has 8.68 billion in cash and no debt, with a net cash position of 8.68 billion or 1,245.66 per share.
| Cash & Cash Equivalents | 8.68B |
| Total Debt | n/a |
| Net Cash | 8.68B |
| Net Cash Per Share | 1,245.66 |
| Equity (Book Value) | 13.71B |
| Book Value Per Share | 2,057.51 |
| Working Capital | 11.74B |
Cash Flow
In the last 12 months, operating cash flow was 1.10 billion and capital expenditures -35.00 million, giving a free cash flow of 1.07 billion.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -35.00M |
| Depreciation & Amortization | 90.25M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.07B |
| FCF Per Share | 152.85 |
Margins
Gross margin is 46.91%, with operating and profit margins of 16.33% and 10.38%.
| Gross Margin | 46.91% |
| Operating Margin | 16.33% |
| Pretax Margin | 14.92% |
| Profit Margin | 10.38% |
| EBITDA Margin | 17.10% |
| EBIT Margin | 16.33% |
| FCF Margin | 9.48% |
Dividends & Yields
This stock pays an annual dividend of 68.00, which amounts to a dividend yield of 3.19%.
| Dividend Per Share | 68.00 |
| Dividend Yield | 3.19% |
| Dividend Growth (YoY) | 89.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.40% |
| Shareholder Yield | 4.59% |
| Earnings Yield | 8.30% |
| FCF Yield | 7.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 26, 2013. It was a forward split with a ratio of 300.
| Last Split Date | Sep 26, 2013 |
| Split Type | Forward |
| Split Ratio | 300 |
Scores
Techno Medica has an Altman Z-Score of 6.85 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.85 |
| Piotroski F-Score | 5 |